Naked antisense double-stranded DNA oligonucleotide efficiently suppresses BCR-ABL positive leukemic cells
In conclusion, ADO technology is an attractive method for therapeutic application.
Source: Investigational New Drugs - Category: Drugs & Pharmacology Source Type: research
More News: Chronic Leukemia | Chronic Myeloid Leukaemia | Drugs & Pharmacology | Genetics | Gleevec | Investigational New Drugs | Leukemia